Jan Schnitzer

Company: Proteogenomics Research Institute for Systems Medicine (PRISM)

Job title: Chief Executive Officer & President


Panel Discussion – Unlocking the Potential of Combinatorial Strategies of Bispecifics in a Clinical Setting 3:30 pm

For more information on this session, please download the full event guide.Read more

day: Day Two

Bispecific Antibodies Engineered to be Pumped into Disease Tissue for Ultra-Low Dose Therapeutic Efficacy 11:15 am

– Outlining how antibodies rely on passive transport mechanisms to reach their targets – Understanding barriers can hinder tissue entry enough to limit targeting/efficacy, even at high, near toxic doses – Caveolae pump engineered bispecific antibodies across endothelium to block key targets inside diseased lung – Discussing how active immunodelivery system improves precision lung tissue…Read more

day: Track B - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.